Journals / İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi / 2018 / Cilt: 8 - Sayı: 2

Evaluation of siblings togetherness and tissue types in celiac disease

Çölyak hastalığında kardeş birlikteliği ve doku tiplerinin değerlendirilmesi

Pages
127–131
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The siblings of all patients diagnosed with celiac disease need to be screened for celiac disease, even if they are asymptomatic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Celiac disease with genetic predisposition is more likely to be seen in patients’ relatives than in the general population.
📊
Key Findings & Data:Results: Celiac disease was detected in a total 10 siblings of 9 (5.96%) patients.
💡
Conclusion & Impact:Conclusion: The siblings of all patients diagnosed with celiac disease need to be screened for celiac disease, even if they are asymptomatic.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Celiac disease with genetic predisposition is more likely to be seen in patients’ relatives than in the general population. In this study, it is aimed to evaluate our patients with celiac disease and their siblings in this respect. Methods: Hundred and fifty-one patients who were followed up with the diagnosis of celiac disease in our pediatric gastroenterology clinic were evaluated. The number of siblings of patients diagnosed with celiac disease, time of diagnosis between siblings, complaints and celiac serology at the diagnosis, stages of Marsh classification, tissue types of human leukocyte antigen (HLA) were evaluated. Results: Celiac disease was detected in a total 10 siblings of 9 (5.96%) patients. Mean ages of the patients, and their siblings were 6.9±3.4 and 6.2±4.4 years, respectively. Two siblings were diagnosed with celiac disease at the same time, in the other patients, the mean duration of diagnosis between the index cases and the siblings was 29±39.5 months. The most common causes of admission of index cases were abdominal pain and growth retardation, and 40% of the siblings were asymptomatic. Tissue transglutaminase antibody IgA values of the patients and their siblings at the time of diagnosis were >200 RU/ml, endomysial antibodies IgA was 1/100 or >1/100 in 6 patients and 8 siblings. Human leukocyte antigen (HLA) tissue types DQA1*05 and/or DQB1*02 were detected in all patients and their siblings. Conclusion: The siblings of all patients diagnosed with celiac disease need to be screened for celiac disease, even if they are asymptomatic.

Özet

Amaç: Genetik yatkınlığı bulunan çölyak hastalığının, hasta yakınlarında görülme olasılığı genel toplumdan daha yüksektir. Bu çalışmada, çölyak hastalarımızın ve kardeşlerinin bu açıdan değerlendirilmesi amaçlanmıştır. Yöntem: Çocuk Gastroenteroloji Kliniğimizde çölyak hastalığı tanısı konularak takibe alınan 151 hasta değerlendirildi. Hastaların kaç kardeşinde çölyak hastalığı saptandığı, kardeşler arası tanı süreleri, tanıdaki yakınmalar ve çölyak serolojileri, Marsh evreleri, insan lökosit antijenleri (HLA) doku tipleri değerlendirildi. Bulgular: Hastalarımızın 9’unun (%5,96) toplam 10 kardeşinde çölyak hastalığı belirlendi. Hastaların ortalama yaşları 6,9±3,4 yıl, kardeşlerinin ise 6,2±4,4 yıl saptandı. İki kardeş aynı zamanda çölyak hastalığı tanısı almıştı, diğer hastalarda, indeks olgu ile kardeşlerinin arasında ki tanı süresi ortalama 29±39,5 ay olarak bulundu. İndeks olguların en sık başvuru nedenleri karın ağrısı ve büyüme geriliği olup, kardeşlerin %40’ı asemptomatik saptandı. Hastaların ve kardeşlerin tanı anındaki doku transglutaminaz antikor Ig A değerleri >200 RU/ml, endomisyum antikor Ig A ise hastaların 6’sında, kardeşlerin ise 8’inde 1/100 veya >1/100 bulundu. İnsan lökosit antijenleri (HLA) doku tiplerinden DQA1*05 ve/vaya DQB1*02 tüm hastalarda ve kardeşlerinde saptandı. Sonuç: Çölyak hastalığı tanısı alan tüm hasta kardeşlerinin asemptomatik olsalarda çölyak hastalığı açısından taranması gerekmektedir.

🔖

Cite This Article

APPAK, Y. Ç., KARAKOYUN, M., GÜNEŞ, S., ÜZÜM, Ö., BARAN, M. (2018). Evaluation of siblings togetherness and tissue types in celiac disease. İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi, Cilt: 8 - Sayı: 2, 127–131. https://ajindex.com/articles/192701

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62:43-52. https://doi.org/10.1136/gutjnl-2011-301346 Dubé C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128:57-67. https://doi.org/10.1053/j.gastro.2005.02.014
  2. Katz KD, Rashtak S, Lahr BD, Melton LJ 3rd, Krause PK, Maggi K, et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol. 2011;106:1333-9. https://doi.org/10.1038/ajg.2011.21
  3. Dalgic B, Sari S, Basturk B, Ensari A, Egritas O, Bukulmez A, et al. Turkish Celiac Study Group. Prevalence of celiac disease in healthy Turkish school children. Am J Gastroenterol. 2011;106:1512-7. https://doi.org/10.1038/ajg.2011.183
  4. Almeida PL, Gandolfi L, Modelli IC, Martins Rde C, Almeida RC, Pratesi R. Prevalence of celiac disease among first degree relatives of Brazilian celiac patients. Arq Gastroenterol. 2008;45:69-72. https://doi.org/10.1590/S0004-28032008000100013
  5. Tursi A, Elisei W, Giorgetti GM, Gaspardone A, Lecca PG, Di Cesare L, et al. Prevalence of celiac disease and symptoms in relatives of patients with celiac disease. Eur Rev Med Pharmacol Sci. 2010;14:567-72.
  6. Bonamico M, Ferri M, Mariani P, Nenna R, Thanasi E, Luparia RP, et al. Serologic and genetic markers of celiac disease: a sequential study in thescreening of first degree relatives. J Pediatr Gastroenterol Nutr. 2006;42:150-4. https://doi.org/10.1097/01.mpg.0000189337.08139.83
  7. Rubio-Tapia A, Van Dyke CT, Lahr BD, Zinsmeister AR, El-Youssef M, Moore SB, et al. Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol. 2008;6:983-7. https://doi.org/10.1016/j.cgh.2008.04.008
  8. Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:572. https://doi.org/10.1097/MPG.0b013e31821a23d0
  9. Goel GK, Pokharna RK, Khatri PC, Senger GS, Joshi A, Khatri M, et al. Prevalence of celiac disease in first-degree siblings of celi